0001140361-15-045387.txt : 20151222
0001140361-15-045387.hdr.sgml : 20151222
20151222175427
ACCESSION NUMBER: 0001140361-15-045387
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151203
FILED AS OF DATE: 20151222
DATE AS OF CHANGE: 20151222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lutwyche Peter
CENTRAL INDEX KEY: 0001628358
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 151303817
MAIL ADDRESS:
STREET 1: C/O TEKMIRA PHARMACEUTICALS CORP.
STREET 2: 100-8800 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
3
1
doc1.xml
FORM 3
X0206
3
2015-12-03
0
0001447028
Arbutus Biopharma Corp
ABUS
0001628358
Lutwyche Peter
C/O ARBUTUS BIOPHARMA CORP.
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Tech. Operations Officer
Common Shares
38758
D
Employee Stock Option (Right to Buy)
5.15
2012-12-10
2022-12-09
Common Shares
5000
D
Employee Stock Option (Right to Buy)
16.40
2014-02-05
2024-02-04
Common Shares
20000
D
Employee Stock Option (Right to Buy)
17.57
2015-03-30
2025-03-30
Common Shares
65000
D
Employee Stock Option (Right to Buy)
17.57
2015-07-09
2025-03-30
Common Shares
35000
D
Warrants
2.60
2012-02-29
2017-03-01
Common Shares
2500
D
Expressed in Canadian dollars.
Date reflected above is date of grant. The option vests as follows: 1/4 on 2/5/2014; 1/4 on 2/5/2015; 1/4 on 2/5/2016; and 1/4 on 2/5/2017.
Date reflected above is date of grant. The option vests as follows: 1/3 on 3/30/2016; 1/3/ on 3/30/2017; and 1/3 on 3/30/2018.
/s/ Peter Lutwyche
2015-12-22